Seven years ago, Intel missed the opportunity to invest in OpenAI, and now its market value has fallen to one OpenAI
bmxphg274
发表于 2024-8-12 12:17:48
1231
0
0
Seven years ago, Intel missed the opportunity to invest in OpenAI, and now its market value has fallen to one OpenAI. American chip giant Intel has been in constant trouble recently. After the second quarter performance and third quarter guidance of the 2024 fiscal year "exploded", Intel was sued by shareholders again, accused of "fraudulently concealing the company's existing problems".
CandyLake.com 系信息发布平台，仅提供信息存储空间服务。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
声明：该文观点仅代表作者本人，本文不代表CandyLake.com立场，且不构成建议，请谨慎对待。
转播
猜你喜欢
- Analysts say the possibility of Qualcomm acquiring Intel is too low: too little cash, too many obstacles
- 애널리스트들은 퀄컴의 인텔 인수 가능성이 너무 낮다고 말한다. 현금이 너무 적고 방해가 너무 많다
- Intel releases Xeon 6 performance core processor
- Intel, Xeon 6 성능 코어 프로세서 출시
- Arm reportedly approached Intel to acquire its product division, but was rejected by the latter
- Arm은 인텔과 제품 부문 인수를 협의한 것으로 알려졌으나 후자가 거절했다
- Intel officially launches Xeon 6 performance core processor to provide technical support for computationally intensive fields such as AI and scientific computing
- 인텔, Xeon 6 성능 코어 프로세서 정식 출시, AI, 과학 컴퓨팅 등 컴퓨팅 집약형 분야에 기술 지원
- Rescuing Intel: White House reportedly to finalize $8.5 billion chip funding
- Intel Technology is expected to complete $8.5 billion in financing by the end of the year; A total of 109 domestic online games were approved in September
-
9月が終わり、映画・テレビ業界が暗躍している。最近、愛奇芸の創始者でCEOのGONG宇氏は、映画・テレビ業界が長短の変化、AIの変化、中国映画・テレビドラマの海外進出の変化の3つの変化を経験していると発表した。 ...- 寒郁轩良
- 昨天 14:17
- 支持
- 反对
- 回复
- 收藏
-
8月のトヨタ自動車（ダイハツ自動車と日野自動車を除く、レクサスを含む）の世界生産台数は前年同月比11.2%減の709571台、世界販売台数は前年同月比3.1%減の826863台だった。 日本本土市場では、トヨタ自動車の8月 ...- SOGO
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
ネットワーク状況監視サイトDownDetectorによると、オーディオストリーミングプラットフォームSpotifyは日曜日に約3時間にわたる障害を経験した後、正常に回復し、ピーク時には米国の4万人以上のユーザーに影響を与 ...- hecgdge4
- 昨天 09:33
- 支持
- 反对
- 回复
- 收藏
-
百済神州（688235.SH）はA株の有名な革新薬企業で、2017-2024年上半期、同社の各期の研究開発投資はA株の化学製薬会社（申万二級）の中で最も高く、研究開発費用は合計600億元を超えた。 しかし、百済神州にとって ...- wylz8473
- 前天 18:36
- 支持
- 反对
- 回复
- 收藏
